- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01727284
MR-Guided Cryoablation of Prostate Bed Recurrences
January 16, 2024 updated by: David A. Woodrum, Mayo Clinic
Technical Success, Safety, and Short and Long-term Efficacy for MR-Guided Cryoablation of Prostate Bed Recurrences
The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Desirae Howe-Clayton
- Phone Number: 507-255-0111
- Email: howe.desirae@mayo.edu
Study Contact Backup
- Name: Deb Berg
- Phone Number: 507-255-8454
- Email: RSTInterventionalOncology@mayo.edu
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic in Rochester
-
Contact:
- Jennifer Murphy
- Phone Number: 507-538-0540
- Email: Murphy.Jennifer@mayo.edu
-
Principal Investigator:
- David A Woodrum, M.D., Ph.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients with "biopsy proven" soft tissue tumor recurrences of prostate fossa
- Surgery is not a desirable alternative therapy at the time of enrollment
- Radiation therapy has failed or not indicated or can be safely postponed
- Tumor size is < 5 cm at its largest diameter
- Tumor does not encompass the rectal wall or external urethral sphincter
- Patient is able to undergo MRI
Exclusion Criteria:
- N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: MR-guided cryoablation (freezing of tissue and/or tumors)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluation of target lesion at 3-6, 12, 24, and 36 month imaging follow-up
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Woodrum, MD, PhD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 12, 2012
Primary Completion (Estimated)
October 1, 2024
Study Completion (Estimated)
October 1, 2024
Study Registration Dates
First Submitted
November 12, 2012
First Submitted That Met QC Criteria
November 14, 2012
First Posted (Estimated)
November 15, 2012
Study Record Updates
Last Update Posted (Actual)
January 17, 2024
Last Update Submitted That Met QC Criteria
January 16, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-002245
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Tumors
-
Istituto Scientifico Romagnolo per lo Studio e...RecruitingProstate-specific Membrane Antigen | mCRPC or Advanced/Metastatic Solid TumorsItaly
-
University of WashingtonNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine Carcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
AmgenCompletedCarcinoma | Cancer | Prostate Cancer | Tumors | Castrate-Resistant Prostate CancerUnited States, Canada, Poland, Hungary, Finland, Mexico
-
Dana-Farber Cancer InstituteBlue Earth Diagnostics, IncNot yet recruitingMetastatic Prostate Cancer | Advanced Prostate Cancer | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
University of UtahNational Cancer Institute (NCI); MultiFunctional Imaging LLCRecruiting
-
Fred Hutchinson Cancer CenterBristol-Myers SquibbNot yet recruitingStage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage III Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
Mayo ClinicWithdrawn
-
Seoul National University HospitalUnknownProstate Cancer | Bladder Cancer | Bladder Tumor | Prostate Tumor
-
M.D. Anderson Cancer CenterActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma | Castration-Resistant...United States
Clinical Trials on MR-guided cryoablation
-
Mayo ClinicRecruitingPrimary Malignant Neoplasm of Prostate (Diagnosis)United States
-
University of California, San FranciscoCompletedUterine FibroidsUnited States
-
Universitair Ziekenhuis BrusselRecruiting
-
University Hospital HeidelbergLudwig-Maximilians - University of Munich; University Hospital, ZürichActive, not recruitingProstate CancerGermany
-
Brahms AGCompletedPatients Presenting With Suspicion of Infection to the EDSpain
-
UMC UtrechtRadboud University Medical Center; Catharina Ziekenhuis Eindhoven; Amsterdam... and other collaboratorsNot yet recruitingLocally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy (LAPSTAR)Locally Advanced Pancreatic AdenocarcinomaNetherlands
-
Juergen DebusRecruiting
-
Odense University HospitalNovo Nordisk A/S; AgeCare Academy of Geriatric Cancer ResearchCompleted
-
AHS Cancer Control AlbertaRecruiting
-
Sunnybrook Health Sciences CentreCompletedMajor Depressive DisorderCanada